A Side-by-Side
Comparison of Popular

Weight Loss

Drugs

Dosage

DOSAGE
FORM

suitable for long-term use

EFFICACY

COVERED BY INSURANCE

COVERED BY MEDICARE

Metformin

1-2

DAILY

YES

99%

100%

Contrave

(NALTREXONE / BUPROPION)

2

DAILY

YES

11%

0%

Phentermine

(ADIPEX-P)

1-3

DAILY

NO

47%

0%

Qsymia

(PHENTERMINE / TOPIRAMATE ER)

1

DAILY

YES

23%

0%

Saxedna

(LIRAGLUTIDE)

1

DAILY

YES

16%

0%

Wegovy

(SEMAGLUTIDE)

1

WEEKLY

YES

20%

0%

Ozempic

(SEMAGLUTIDE)

1

WEEKLY

YES

%

%

Mounjaro

(TIRZEPATIDE)

1

WEEKLY

YES

13%

43%

Metformin***

Suitable for long term use:

YES

Covered by insurance:

99%

Covered by Medicare:

100%

DOSAGE

1-2

DAILY

FORM

EFFICACY

Contrave

(NALTREXONE / BUPROPION)

Suitable for long term use:

YES

Covered by insurance:

11%

Covered by Medicare:

0%

DOSAGE

2

DAILY

FORM

EFFICACY

Phentermine

(ADIPEX-P)

Suitable for long term use:

NO

Covered by insurance:

47%

Covered by Medicare:

0%

DOSAGE

1-3

DAILY

FORM

EFFICACY

Qsymia

(PHENTERMINE / TOPIRAMATE ER)

Suitable for long term use:

YES

Covered by insurance:

23%

Covered by Medicare:

0%

DOSAGE

1-2

DAILY

FORM

EFFICACY

Saxedna

(LIRAGLUTIDE)

Suitable for long term use:

Yes

Covered by insurance:

16%

Covered by Medicare:

0%

DOSAGE

1

DAILY

FORM

EFFICACY

Wegovy

(SEMAGLUTIDE)

Suitable for long term use:

YES

Covered by insurance:

20%

Covered by Medicare:

0%

DOSAGE

1

DAILY

FORM

EFFICACY

Ozempic

(SEMAGLUTIDE)

Suitable for long term use:

YES

Covered by insurance:

%

Covered by Medicare:

%

DOSAGE

1

DAILY

FORM

EFFICACY

Tirzepatide

(MOUNJARO)

Suitable for long term use:

YES

Covered by insurance:

13%

Covered by Medicare:

43%

DOSAGE

1

DAILY

FORM

EFFICACY